Empty Capsules Market Report and Forecast 2023-2031

Global Empty Capsules Market Report and Forecast 2023-2031

Global Empty Capsules Market Outlook
The global empty capsules market value was USD 2.27 billion in 2022, driven by the increasing demand for capsule-based pharmaceutical and nutraceutical products across the globe. The market size is anticipated to grow at a CAGR of 7% during the forecast period of 2023-2031 to achieve a value of USD 4.17 billion by 2031.

Empty Capsules Introduction

Empty capsules are an essential component in the pharmaceutical and nutraceutical industries, providing a convenient and effective means of administering medication and dietary supplements. They are typically made from gelatin, derived from animal collagen, or hydroxypropyl methylcellulose (HPMC), a plant-based alternative, and come in various sizes and colors to accommodate different formulations and dosages. The global empty capsules market encompasses both gelatin capsules and non-gelatin capsules, catering to a wide range of applications, including traditional drugs, herbal medicines, and dietary supplements.

Empty Capsules Market Scenario

The global empty capsules market has experienced significant growth in recent years, driven by factors such as the increasing demand for capsule-based pharmaceutical and nutraceutical products, advancements in capsule manufacturing technologies, and a growing preference for vegetarian capsules.

North America: The largest market for empty capsules, driven by factors such as the advanced pharmaceutical and nutraceutical industries, a high prevalence of chronic diseases, and the presence of major capsule manufacturers.

Europe: The second-largest market, with increasing demand for empty capsules due to a growing aging population, a supportive regulatory framework, and an expanding nutraceutical sector.

Asia-Pacific: Expected to witness the highest growth rate due to factors such as a rapidly aging population, increasing prevalence of chronic diseases, and growing investments in healthcare infrastructure.

Empty Capsules Market Segmentations

Market Breakup by Type

Gelatin Capsules
Non-Gelatin Capsules

Market Breakup by Functionality

Immediate-Release Capsules
Sustained-Release Capsules
Delayed-Release Capsules

Market Breakup by Application

Antibiotic
Antibacterial Drugs
Dietary Supplements
Antacid
Antiflatulent Preparations
Antianemic Preparations
Anti-Inflammatory Drugs
Cardiovascular Therapy Drugs
Cough and Cold Drugs
Others

Market Breakup by End User

Pharmaceutical Industry
Nutraceutical Industry
Cosmetic Industry and Research Laboratories

Market Breakup by Region

North America

United States of America
Canada

Europe

United Kingdom
Germany
France
Italy
Others

Asia Pacific

China
Japan
India
ASEAN
Australia
Others

Latin America

Brazil
Argentina
Mexico
Others

Middle East and Africa

Saudi Arabia
United Arab Emirates
Nigeria
South Africa
Others

Key Trends in the Empty Capsules Market

Some key trends of the market are as follows:

Growing demand for capsule-based pharmaceutical and nutraceutical products: The increasing prevalence of chronic diseases and a growing awareness of the benefits of dietary supplements have contributed to the rising demand for capsule-based products, driving the growth of the empty capsules market
Advancements in capsule manufacturing technologies: The development of new technologies, such as capsule filling machines and capsule coating systems, has improved the efficiency and quality of capsule manufacturing, contributing to market expansion
Increasing preference for vegetarian capsules: A growing number of consumers are opting for plant-based alternatives to traditional gelatin capsules due to dietary restrictions, religious beliefs, or concerns about animal-derived products, driving the demand for non-gelatin capsules

Empty Capsules Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

ACG
CapsCanada
Bright Pharma Caps
Lonza
SavoiurCaps
Comed Chemicals Limited
NATURAL CAPSULES LIMITED
Wuhan Carma Technology Co., Ltd
Goerlich Pharma GmbH
NecLife Lifesciences Ltd
HealthCaps India Ltd
Erawat Pharma Limited
QUALICAPS
SUHEUNG co., ltd
Fortcaps
SNAIL PHARMA INDUSTRY
Roxlor
Sunil Healthcare Limited
H & CARE Incorp
SHAOXING KANGKE CAPSULE CO., LTD

1 Preface

1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology

2 Executive Summary

3 Global Empty Capsules Market Overview

3.1 Global Empty Capsules Market Historical Value (2016-2022)
3.2 Global Empty Capsules Market Forecast Value (2023-2031)

4 Global Empty Capsules Market Landscape

4.1 Global Empty Capsules Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Empty Capsules Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by End User
4.2.3 Analysis by Applications

5 Global Empty Capsules Market Dynamics

5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis

6 Global Empty Capsules Market Segmentation

6.1 Global Empty Capsules Market, by Type
6.1.1 Market Overview
6.1.2 Gelatin Capsules
6.1.3 Non-Gelatin Capsules
6.2 Global Empty Capsules Market, by Functionality
6.2.1 Market Overview
6.2.2 Immediate-Release Capsules
6.2.3 Sustained-Release Capsules
6.2.4 Delayed-Release Capsules
6.3 Global Empty Capsules Market, by Application
6.3.1 Market Overview
6.3.2 Antibiotic
6.3.3 Antibacterial Drugs
6.3.4 Dietary Supplements
6.3.5 Antacid
6.3.6 Antiflatulent Preparations
6.3.7 Antianemic Preparations
6.3.8 Anti-Inflammatory Drugs
6.3.9 Cardiovascular Therapy Drugs
6.3.10 Cough and Cold Drugs
6.3.11 Others
6.4 Global Empty Capsules Market, by End User
6.4.1 Market Overview
6.4.2 Pharmaceutical Industry
6.4.3 Nutraceutical Industry
6.4.4 Cosmetic Industry and Research Laboratories
6.5 Global Empty Capsules Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa

7 North America Empty Capsules Market

7.1 Market Share by Country
7.2 United States of America
7.3 Canada

8 Europe Empty Capsules Market

8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others

9 Asia Pacific Empty Capsules Market

9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others

10 Latin America Empty Capsules Market

10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others

11 Middle East and Africa Empty Capsules Market

11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others

12 Patent Analysis

12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players

13 Grants Analysis

13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization

14 Funding Analysis

14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography

15 Partnership and Collaborations Analysis

15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography

16 Regulatory Framework

16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others

17 Supplier Landscape

17.1 ACG
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 CapsCanada
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Bright Pharma Caps
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Lonza
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 SavoiurCaps
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Comed Chemicals Limited.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 NATURAL CAPSULES LIMITED
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Wuhan Carma Technology Co., Ltd.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Goerlich Pharma GmbH
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 NecLife Lifesciences Ltd
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 HealthCaps India Ltd.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Erawat Pharma Limited.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 QUALICAPS
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 SUHEUNG co., ltd.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Fortcaps
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 SNAIL PHARMA INDUSTRY
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 Roxlor
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
17.18 Sunil Healthcare Limited
17.18.1 Financial Analysis
17.18.2 Product Portfolio
17.18.3 Demographic Reach and Achievements
17.18.4 Mergers and Acquisitions
17.18.5 Certifications
17.19 H & CARE Incorp
17.19.1 Financial Analysis
17.19.2 Product Portfolio
17.19.3 Demographic Reach and Achievements
17.19.4 Mergers and Acquisitions
17.19.5 Certifications
17.20 SHAOXING KANGKE CAPSULE CO., LTD
17.20.1 Financial Analysis
17.20.2 Product Portfolio
17.20.3 Demographic Reach and Achievements
17.20.4 Mergers and Acquisitions
17.20.5 Certifications

18 Global Dental Laboratories Distribution Model (Additional Insight)

18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment

19 Key Opinion Leaders (KOL) Insights (Additional Insight)

20 Company Competitiveness Analysis (Additional Insight)

20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies

21 Pricing Models and Strategies (Additional Insight)

21.1 Overview
21.2 Cost Model
21.2.1 Manufacturing Cost Analysis
21.2.2 Procurement Cost Analysis
21.2.3 Clinical Trial Cost Factors
21.3 Pricing Strategies
21.3.1 Competitor Pricing Analysis
21.3.2 Key Assessment of Product Attributes
21.3.3 Pricing Benchmark

Companies Mentioned

Acg
Capscanada
Bright Pharma Caps
Lonza
Savoiurcaps
Comed Chemicals Limited.
Natural Capsules Limited
Wuhan Carma Technology Co. Ltd.
Goerlich Pharma GmbH
Neclife Lifesciences Ltd
Healthcaps India Ltd.
Erawat Pharma Limited.
Qualicaps
Suheung Co. Ltd.
Fortcaps
Snail Pharma Industry
Roxlor
Sunil Healthcare Limited
H & Care Incorp
Shaoxing Kangke Capsule Co. Ltd

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	147
Published	May 2023
Forecast Period	2023 - 2031
Estimated Market Value ( USD ) in 2023	$ 2.43 Billion
Forecasted Market Value ( USD ) by 2031	$ 4.17 Billion
Compound Annual Growth Rate	7.0%
Regions Covered	Global
No. of Companies Mentioned	20

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5698EUR$5,999USD£4,780GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€7597EUR$7,999USD£6,374GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€9497EUR$9,999USD£7,967GBP